title: Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM).
abstract: OBJECTIVE
  To determine the pattern of electroretinographic change after an intravitreal ranibizumab (Lucentis(®)) injection for the treatment of choroidal neovascular membrane (CNVM).
  
  
  METHODS
  A prospective interventional case series of patients treated by intravitreal ranibizumab injection. Best corrected visual acuity, optical coherence tomography (OCT), and multifocal electroretinography (mfERG) were assessed prior to treatment, and 2 weeks, 1 and 3 months after treatment. Primary outcome was the functional change in amplitude and implicit time by mfERG and secondary outcome was the structural change in macular thickness by optical coherence tomography (OCT).
  
  
  RESULTS
  Twenty-six eyes from 25 consecutive patients were enrolled. At 3 months after treatment, the mean visual acuity (VA) improved from 1.06 to 0.84 logMAR (P = 0.034) and the mean macular thickness decreased from 389.7 to 264.4 microns (P = 0.003). The mean implicit time of the central zone showed an improvement at 3 months after treatment when compared with the response at baseline (P = 0.024) and at 1 month (P = 0.013) but the mean amplitude showed no significant change. In subgroup analysis, the eyes with initial visual acuity (VA) ≥ 20/200 had a significant improvement in mean implicit time of the peripheral zone at 2 weeks after treatment (P = 0.028). The OCT revealed a significant decrease (P < 0.003) in macular thickness at 1 and 3 months postoperatively.
  
  
  CONCLUSIONS
  The mean implicit time of the central zone improved significantly at 3 months after treatment, whereas the mean amplitude showed no significant change. The macular thickness decreased significantly after the treatment, while VA improved to a lesser extent.
authors: Retina Unit, Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
authors: Patama
authors: P
authors: Bhurayanontachai
authors: Mansing
authors: M
authors: Ratanasukon
authors: Pichai
authors: P
authors: Jirarattanasopa
references: Doc Ophthalmol. 2007 Jan;114(1):37-44
references: 17216267
references: Retina. 2006 Mar;26(3):270-4
references: 16508425
references: Doc Ophthalmol. 2003 Mar;106(2):105-15
references: 12678274
references: Br J Ophthalmol. 2009 Oct;93(10):1396-400
references: 19628500
references: J Neurol Sci. 2008 May 15;268(1-2):145-9
references: 18207164
references: Am J Ophthalmol. 2007 Dec;144(6):850-857
references: 17949673
references: Arch Ophthalmol. 2003 Oct;121(10):1404-14
references: 14557176
references: Clin Ophthalmol. 2007 Jun;1(2):167-75
references: 19668506
references: Vision Res. 1992 Mar;32(3):433-46
references: 1604830